State of Wisconsin Investment Board
KROS icon

State of Wisconsin Investment Board’s Keros Therapeutics KROS Stock Holding History

State of Wisconsin Investment Board’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$176K Sell
15,932
-3,903
-20% -$60.3K ﹤0.01% 2366
2025
Q4 		$404K Sell
19,835
-2,389
-11% -$41.9K ﹤0.01% 2041
2025
Q3 		$352K Sell
22,224
-49,700
-69% -$734K ﹤0.01% 2043
2025
Q2 		$960K Buy
+71,924
New +$971K ﹤0.01% 1596
2025
Q1 		– Sell
-44,434
Closed -$703K – 2293
2024
Q4 		$703K Buy
44,434
+16,714
+60% +$869K ﹤0.01% 1657
2024
Q3 		$1.61M Sell
27,720
-4,038
-13% -$199K ﹤0.01% 1397
2024
Q2 		$1.45M Buy
31,758
+12,827
+68% +$689K ﹤0.01% 1423
2024
Q1 		$1.25M Sell
18,931
-9,960
-34% -$591K ﹤0.01% 1370
2023
Q4 		$1.15M Buy
28,891
+2,183
+8% +$68.5K ﹤0.01% 1352
2023
Q3 		$851K Buy
26,708
+11,974
+81% +$447K ﹤0.01% 1455
2023
Q2 		$592K Sell
14,734
-3,205
-18% -$140K ﹤0.01% 1745
2023
Q1 		$766K Buy
17,939
+2,512
+16% +$127K ﹤0.01% 1624
2022
Q4 		$741K Buy
15,427
+1,037
+7% +$48.4K ﹤0.01% 1687
2022
Q3 		$541K Buy
14,390
+404
+3% +$14K ﹤0.01% 1936
2022
Q2 		$386K Sell
13,986
-3,914
-22% -$172K ﹤0.01% 2207
2022
Q1 		$973K Hold
17,900
– – ﹤0.01% 1647
2021
Q4 		$1.05M Hold
17,900
– – ﹤0.01% 1438
2021
Q3 		$708K Hold
17,900
– – ﹤0.01% 1567
2021
Q2 		$760K Hold
17,900
– – ﹤0.01% 1546
2021
Q1 		$1.1M Sell
17,900
-200
-1% -$12.7K ﹤0.01% 1340
2020
Q4 		$1.28M Buy
18,100
+6,900
+62% +$435K ﹤0.01% 1272
2020
Q3 		$432K Hold
11,200
– – ﹤0.01% 1534
2020
Q2 		$420K Buy
+11,200
New +$345K ﹤0.01% 1477

Other funds holding KROS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

State of Wisconsin Investment Board's KROS Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Keros Therapeutics (KROS) stake by 20% in Q1 2026, selling an estimated $60.3K and leaving 15,932 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #2366.

State of Wisconsin Investment Board first reported a position in KROS in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.61M in Q3 2024. 151 funds tracked by Wall St. Rank hold KROS as of Q1 2026.

  • State of Wisconsin Investment Board held 15,932 shares of Keros Therapeutics worth $176K as of Q1 2026.
  • State of Wisconsin Investment Board sold 3,903 Keros Therapeutics shares in Q1 2026, an estimated $60.3K.
  • Keros Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2366 holding.
  • State of Wisconsin Investment Board first reported a position in Keros Therapeutics in Q2 2020 and has held it in 23 quarters since.
  • State of Wisconsin Investment Board's Keros Therapeutics position peaked at $1.61M in Q3 2024.
  • 151 funds tracked by Wall St. Rank held Keros Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.